Key result
Microtubule plus-end tracking proteins direct NaV1.5 cardiomyocyte trafficking, revealing novel anti-arrhythmic targets.
Why the study?
Decreased NaV1.5 levels at the plasma membrane cause lethal cardiac arrhythmias, but the mechanisms involved in the targeted delivery and microtubule-mediated trafficking of NaV1.5 require further elucidation.
Understanding the role of +TIPs in NaV1.5 trafficking provides novel insights into the mechanisms of arrhythmogenic diseases and potential targets for anti-arrhythmic therapies.
The cardiac sodium channel NaV1.5 is an essential modulator of cardiac excitability, with decreased NaV1.5 levels at the plasma membrane and consequent reduction in sodium current (INa) leading to potentially lethal cardiac arrhythmias. NaV1.5 is distributed in a specific pattern at the plasma membrane of cardiomyocytes, with localization at the crests, grooves, and T-tubules of the lateral membrane and particularly high levels at the intercalated disc region. NaV1.5 forms a large macromolecular complex with and is regulated by interacting proteins, some of which are specifically localized at either the lateral membrane or intercalated disc. One of the NaV1.5 trafficking routes is via microtubules (MTs), which are regulated by MT plus-end tracking proteins (+TIPs). In our search for mechanisms involved in targeted delivery of NaV1.5, we here provide an overview of previously demonstrated interactions between NaV1.5 interacting proteins and +TIPs, which potentially (in)directly impact on NaV1.5 trafficking. Strikingly, +TIPs interact extensively with several intercalated disc- and lateral membrane-specific NaV1.5 interacting proteins. Recent work indicates that this interplay of +TIPs and NaV1.5 interacting proteins mediates the targeted delivery of NaV1.5 at specific cardiomyocyte subcellular domains, while also being potentially relevant for the trafficking of other ion channels. These observations are especially relevant for diseases associated with loss of NaV1.5 specifically at the lateral membrane (such as Duchenne muscular dystrophy), or at the intercalated disc (for example, arrhythmogenic cardiomyopathy), and open up potential avenues for development of new anti-arrhythmic therapies.
No takes yet. Share an insight, caveat, or question.
Marchal et al. (2023) conducted a review in Cardiac arrhythmias. Microtubule plus-end tracking proteins (+TIPs) was evaluated. Microtubule plus-end tracking proteins interact with NaV1.5 interacting proteins to mediate targeted delivery of NaV1.5 to specific cardiomyocyte domains, offering potential targets for anti-arrhythmic therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: